Solifenacin Alternatives Compared
Solifenacin | Vibegron | Gemtesa (vibegron) |
|
---|
Solifenacin | Vibegron | Gemtesa (vibegron) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Overactive Bladder, Urinary Incontinence, Neurogenic Bladder, Urinary Frequency, Neurogenic Detrusor Overactivity. Solifenacin may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Overactive Bladder. Vibegron may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Overactive Bladder. Gemtesa may also be used for purposes not listed in this medication guide. |
Related suggestions Overactive Bladder
Popular comparisons
|
|||||||||||||||
More about Solifenacin | More about Vibegron | More about Gemtesa (vibegron) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Solifenacin has an average rating of 5.4 out of 10 from a total of 199 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 37% reported a negative effect. |
Vibegron has an average rating of 7.7 out of 10 from a total of 194 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 13% reported a negative effect. |
Gemtesa has an average rating of 7.7 out of 10 from a total of 187 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 12% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Solifenacin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Gemtesa prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
Brand Names | ||||||||||||||||||
VESIcare, VESIcare LS | Gemtesa |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
68 hours |
30.8 hours |
30.8 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 488 drugs are known to interact with Solifenacin:
|
A total of 17 drugs are known to interact with Vibegron:
|
A total of 17 drugs are known to interact with Gemtesa:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
November 19, 2004 |
December 23, 2020 |
December 23, 2020 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.